HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, K. C-W. Articles by Cooper, A. D. Search for Related Content PubMed PubMed Citation Articles by Yu, K. C-W. Articles by Cooper, A. D. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 40, 1899-1910, October 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver

Correspondence to: Allen D. Cooper

The isolated perfused mouse liver was utilized to evaluate the relative contribution of various molecules believed to participate in the removal of chylomicron remnants by the liver. Sixty percent of asialofetuin was removed from the perfusate per pass; bovine serum albumin was not removed. Normal mouse livers removed chylomicron remnants more efficiently (40;–50%/pass) than nascent chylomicrons (10;–20%/pass). The fractional removal rate of remnants decreased as their concentration in the perfusate increased demonstrating saturability. Remnant removal by livers of low density lipoprotein receptor-deficient (LDLRD) mice paralleled that of normal mice at low remnant concentrations (0.05, 0.2 µg protein/ml); as concentration increased (4;–16 µg protein/ml), removal by LDLRD livers was reduced. About 50% of the capacity to remove remnants was due to the LDL receptor. The role of the LDLR-related protein (LRP) was estimated using the receptor-associated protein (RAP). Four µg/ml of RAP inhibited only LRP; it reduced the removal of remnants by 30;–40% in normal livers. When RAP was included in the perfusate of LDLRD livers, remnant removal persisted but was diminished, particularly late in the perfusion; the capacity was ~30% of controls. The present study has established that there is more than one mechanism operating for the removal of chylomicron remnants by the liver, provides estimates of the concentration of each to the removal of remnants, and indicates a method for further studies.

It is concluded that in normal livers, the LDL receptor has the greatest capacity for removing chylomicron remnants. The LRP contributes to the process as well and a third component, perhaps "sequestration," accounts for up to 30% of the capacity for the initial removal of chylomicron remnants.—Yu, K. C-W., Y. Jiang, W. Chen, and A. D. Cooper. Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver. J. Lipid Res. 1999. 40: 1899;–1910.

Supplementary key words: liver, LDL receptor, LDL receptor-related protein, heparan sulfate proteoglycans, space of Disse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Grosskopf, N. Baroukh, S.-J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2573 - 2579. [Abstract] [Full Text] [PDF]

				S.-J. Lee, S. Kadambi, K. C-W. Yu, C. David, S. Azhar, A. D. Cooper, and S. Y. Choi Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase J. Lipid Res., January 1, 2005; 46(1): 27 - 35. [Abstract] [Full Text] [PDF]

				S.-J. Lee, I. Grosskopf, S. Y. Choi, and A. D. Cooper Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158->Cys), and E3-Leiden J. Lipid Res., December 1, 2004; 45(12): 2199 - 2210. [Abstract] [Full Text] [PDF]

				L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF]

				J. W. Burgess and Y. L. Marcel Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface J. Lipid Res., September 1, 2001; 42(9): 1413 - 1420. [Abstract] [Full Text] [PDF]

				K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E J. Lipid Res., November 1, 2000; 41(11): 1715 - 1727. [Abstract] [Full Text]